function only in some tissues or only at some stages? A pile of bricks is not a house. How the structural genes work together in a concerted manner, properly scheduled and integrated, is the leading problem not only of genetics but also of embryology and teratology.
Human genetics and that part of the science concerned with disease, medical genetics, have also developed rapidly in the last 10 to 15 years. Progress is enslaved to technics-in this case biochemical, cytologic, and statistical. In the last decade we have acquired biochemical methods for analyzing phenotypic variation all the way down to differences in the amino acid sequence of proteins; cytologic methods for scrutinizing the chromosomes of man which, albeit crude, have revealed a myriad of changes completely unknown, although I will not say undreamed of, merely 6 years ago; methods for statistical study, especially in the realm of genetic linkage, by which mapping of man's chromosome is possible. By advances in general genetics the understanding of disease has been enhanced. Contrariwise, the close stuidy of disease has contributed to advances in general genetics. TIhe best example, perhaps, is the demonstration that a main function of genes is to specify the able 1. 13 ). Biochemically also this is a distinct entity. The mucopolysaccharide keratosulfate is excreted in the urine in large amounts. 13 The inheritance is autosomal recessive ( fig. 13 ). By the time they reach their teens all these patients are likely to have aortic regurgitation. The anatomic change responsible for aortic leak is not yet known.
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.. Phleochronocytomai(n. at nrofl)n)natsis. iGCafC-an-la. spots As to the treatment of genetic disorders of the cardiovascular system, reference can be made to xanthomatosis and an analogy drawn to phenylketonuria and galactosemia in which dietary measures offer some benefit.
I-y-
That all disease is to some extent environmentally conditioned or influenced allows room for therapeutic manipulation, admittedly now limited in many instances. Undoubtedly in time we will have means to change drastically the genetic machinery of the cell-not so easily the DNA itself but almost certainly the steps between DNA and the protein it synthesizes. Given, for example, an enzyme molecule which is warped as a result of mutation and which has, let us say, only 2 per cent of the activity of normal enzyme, methods for effecting a 10-fold increase in the amount of the warped enzyme synthesized, through measures directed at the intermediate steps, would raise enzyme activity to 20 per cent of normal and might make the difference between healthy life and death.
It is hoped that sociologic and ethical developments will keep pace with the scientific ones in this sensitive area. At any rate, a gloomy outlook for the future of therapy of genetic disease is not justified. Therapy of infectiouts disease was pretty gloomy less than a century ago. 
